ANGO angiodynamics.com Expected net earnings per share growth this year
AngioDynamics, Inc. (ANGO) management is successfully reducing debt, striving for net profit through asset optimization. The EPS growth trend compared to last year, as seen on the GURU.Markets chart, confirms this trajectory, where -81.30 captures the magnitude of this parameter. The issuer is executing a radical pivot, replacing legacy products with innovative clot removal systems to dominate minimally invasive surgery and oncology.
Analytical breakdowns and data insights for company AngioDynamics, Inc. (ANGO)
- stock quotes and analyst forecast:
- market capitalization data:
- shareholders' equity book value data:
- debt and solvency information:
Total Debt to Capital AngioDynamics, Inc.|ANGO - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio angiodynamics.com|ANGO - Company Aggregate Debts|Debts to Book Value AngioDynamics Inc.|ANGO - Company Long-Term Debt|Company Short-Term Indebtedness AngioDynamics|Intermediate Liquidity Ratio angiodynamics.com
- earnings and valuation multiples indicators:
ANGO - Company Net Income|Company Profit Forecast AngioDynamics, Inc.|ANGO - P/E Multiple|Forward P/E Multiple AngioDynamics Inc.|ANGO - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation AngioDynamics Inc.|ANGO - Operating profit EBITDA|Net earnings per share for the trailing year AngioDynamics|ANGO - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months angiodynamics.com|ANGO - Earnings per share growth in current year|Expected net earnings per share growth next year AngioDynamics, Inc.
Fundamental valuation:ANGO AngioDynamics Inc
To assess asset quality, an investor analyzes the growth rate of earnings per share, which allows them to filter out short-term noise and identify a sustainable profitability trend. By examining the history of annual net income per share, one can evaluate the effectiveness of AngioDynamics, Inc. (ANGO) transitioning toward high-margin medical platforms and the activation of operating leverage amid the stagnation of its legacy catheter segment.
Main competitors
Earnings per share growth this year ISRG|Earnings per share growth in current year Danaher Corp|Becton Dickinson & Company (BDX) - Expected net earnings per share growth this year|Net earnings per share growth this year STE (STERIS plc)|Net earnings per one share growth for the current year WST|Earnings per share growth in current year Baxter BAX|Earnings per share increase in current year MASI|STVN: Net earnings per share growth this year|TFX - Earnings growth in current year|Merit Medical Systems (MMSI) - Earnings per share growth in current year|Net earnings per share growth this year envistaco.com|ICUI (ICU Medical) - Earnings growth in current year|Earnings per share growth rate in current year Dentsply Sirona Inc XRAY|Earnings per share growth in current year LeMaitre (LMAT)|AtriCure Medical - Earnings per share growth this year|STAAR Surgical Company - Net earnings per share growth this year|Net earnings per one share growth for the current year NAGE (niagenbioscience.com)|ZIMV - Earnings per share growth in current year|Expected net earnings per share growth this year Cerus Corp. CERS|TKNO: Earnings growth in current year|Monogram Orthopedics Inc. (MGRM) - Earnings growth in current year|Earnings per share growth in current year Sharps Technology Inc|Earnings per share growth this year INFU (InfuSystem Inc)|Earnings growth in current year UTMD|korumedical.com (KRMD) - Net earnings per share change in current year|Earnings growth in current year NYXH (Nyxoah, S.A.)|Expected net earnings per share growth this year Microbot Medical, Inc (MBOT)|PDEX - Earnings per share growth in current year|Earnings per share growth rate in current year zentek.com|ELUT: Earnings growth in current year|Earnings per share growth this year MLSS|Net earnings per share growth this year NXGL|Earnings per share growth rate in current year Retractable Tech RVP|Earnings per share growth in current year Harvard Bioscience (HBIO)|femasys.com - Earnings per share growth this year|Earnings growth in current year MHUA (Meihua Medical Technologies Co., Ltd.)|Earnings growth in current year Predictive Oncology Inc POAI|CJMB - Earnings per share growth in current year|Atrion Corporation Inc. (ATRI) - Net earnings per share growth this year|NURO: Earnings growth in current year
